샘플 요청 목록

 카트 문의
시장보고서
상품코드
1874624

세계의 계산생물학 시장

Computational Biology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 계산생물학 시장은 2030년까지 284억 달러에 달할 전망

2024년에 105억 달러로 추정되는 세계의 계산생물학 시장은 2024-2030년의 분석 기간에 CAGR 18.0%로 성장하며, 2030년까지 284억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 Drug Discovery·질환 모델링 용도는 18.0%의 CAGR을 기록하며, 분석 기간 종료시점으로 157억 달러에 달할 것으로 예측됩니다. 또 세포·생물학적 시뮬레이션 용도 부문의 성장률은 분석 기간에 16.1%의 CAGR로 추정되고 있습니다.

미국 시장은 29억 달러로 추정되는 한편, 중국은 17.1%의 CAGR로 성장할 것으로 예측됩니다.

미국의 계산생물학 시장은 2024년에 29억 달러로 추정되고 있습니다. 세계 2위의 경제대국인 중국은 2024-2030년의 분석 기간에 17.1%의 CAGR로 추이하며, 2030년까지 43억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 16.0%, 15.4%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 13.1%의 CAGR로 성장할 것으로 예측됩니다.

세계의 계산생물학 시장 - 주요 동향과 촉진요인의 개요

계산생물학은 생명과학 분야의 연구와 혁신을 어떻게 변화시키고 있는가?

계산생물학은 생물학적 데이터에 수학적 모델, 알고리즘, 데이터 분석 기술을 적용하여 생명과학 분야에 혁명을 일으키고 있으며, 지금까지 밝혀내기 어려웠던 복잡한 생물학적 과정의 해명을 돕고 있습니다. 이 다학제적 분야는 생물학, 컴퓨터 과학, 수학을 통합하여 유전자 발현과 단백질 상호작용에 대한 이해에서 전체 생물 시스템의 거동 시뮬레이션에 이르기까지 생물학적 문제를 해결하기 위해 노력하고 있습니다. 계산생물학은 특히 유전체학, 단백질체학, 시스템생물학, 신약개발 분야에서 현대의 연구에서 매우 중요한 역할을 하고 있습니다. 이를 통해 과학자들은 인간 유전체 및 마이크로바이옴 데이터와 같은 대규모 데이터세트를 전례 없는 정확도로 신속하게 분석할 수 있게 되어 맞춤형 의료, 질병 모델링, 진화 생물학 분야에서 획기적인 진전을 이룰 수 있게 되었습니다. 생물학적 데이터가 기하급수적으로 증가함에 따라 계산생물학의 중요성은 계속 증가하고 있으며, 연구자들에게 의미 있는 발견을 추출하고, 새로운 치료법을 개발하며, 분자 및 시스템 수준에서 생명의 근본적인 메커니즘을 이해할 수 있는 툴을 제공합니다.

계산생물학을 이끄는 기술 발전은 무엇인가?

계산생물학 분야는 방대한 생물학적 데이터의 처리 및 해석 능력을 확대하는 기술 혁신에 힘입어 괄목할 만한 발전을 보이고 있습니다. 가장 영향력 있는 기술 중 하나는 차세대 염기서열 분석(NGS)으로, DNA와 RNA의 염기서열 분석에 필요한 시간과 비용을 획기적으로 줄이고, 계산 생물학 툴이 유전적 변이, 돌연변이, 패턴을 밝히기 위해 처리할 수 있는 대규모 데이터세트를 생성하고 있습니다. 여기에 고성능 컴퓨팅(HPC)의 발전으로 복잡한 생물학적 네트워크와 대규모 데이터를 기존의 몇 분의 1의 시간으로 분석할 수 있게 되었습니다. 인공지능(AI)과 머신러닝도 계산생물학을 변화시키고 있으며, 예측 모델링, 패턴 인식, 자동 가설 생성, 신약 개발 및 맞춤 의료 등의 분야에서 예측 모델링, 패턴 인식, 자동 가설 생성을 가능하게 하고 있습니다. AI 알고리즘은 방대한 생물학적 데이터세트를 분석하여 약물과 표적 분자의 상호작용, 치료에 대한 환자의 반응, 심지어 질병 발생을 예측할 수 있습니다. 또한 클라우드 컴퓨팅은 데이터 저장 및 처리를 위한 확장 가능한 리소스를 제공함으로써 계산생물학을 보다 쉽게 이용할 수 있게 하고, 전 세계 연구팀 간의 협력을 촉진하고 있습니다. 이러한 발전은 연구를 크게 가속화하고, 생물 시스템의 보다 정교한 모델 구축, 신속한 신약 개발, 복잡한 질병에 대한 심층적인 인사이트를 가능하게 합니다.

계산생물학은 다양한 연구 분야에서 어떻게 적용되고 있는가?

계산생물학은 생명과학의 다양한 분야에 적용되어 유전체학, 신약개발, 시스템생물학, 진화생물학에서 매우 중요한 역할을 하고 있습니다. 유전체학 분야에서는 계산 툴을 이용하여 전 유전체를 해독하고 분석하여 유전성 질환, 진화, 약물에 대한 개인별 반응에 대한 지식을 얻을 수 있으며, 이는 맞춤형 의료의 기반을 형성하고 있습니다. 유전적 변이를 식별하고 단백질 기능에 미치는 영향을 예측함으로써, 계산생물학은 암, 알츠하이머병, 당뇨병과 같은 질병의 유전적 기반을 더 깊이 이해할 수 있게 해줍니다. 신약개발 분야에서는 계산 모델이 약물 후보물질과 생물학적 표적의 상호작용을 시뮬레이션하여 실험실 테스트에 필요한 시간과 비용을 크게 절감할 수 있습니다. 이러한 모델은 임상시험에 들어가기 전에 잠재적 치료제의 효능과 안전성을 예측하는 데 도움이 되며, 신약 개발 과정의 효율성을 높이는 데 기여합니다. 시스템 생물학에서는 대사 경로, 세포 과정과 같은 생물학적 시스템 전체를 모델링하기 위해 계산적 방법을 사용하여 유전자, 단백질, 대사 산물 간의 상호작용이 생물의 복잡한 행동을 어떻게 유도하는지를 규명합니다. 이러한 종합적인 이해는 잠재적 치료 표적 발굴과 다인자 질환의 치료제 개발에 있으며, 매우 중요합니다. 진화 생물학도 계산 생물학의 혜택을 받고 있으며, 대규모 데이터세트를 통해 종의 진화 역사를 추적하고, 자연 선택이 유전체에 미치는 영향을 이해하고, 생물이 환경 변화에 어떻게 적응할 것인지 예측할 수 있습니다. 이러한 다양한 분야에서 계산생물학은 과학자들이 생물학적 복잡성을 이해하고 데이터를 실용적인 지식으로 전환할 수 있게 해줍니다.

계산생물학 시장의 성장을 이끄는 요인은 무엇인가?

계산생물학 시장의 성장은 기술 발전과 연구 수요의 진화를 반영하는 여러 가지 주요 요인에 의해 주도되고 있습니다. 주요 촉진요인 중 하나는 차세대 염기서열 분석(NGS), 크리스퍼 유전자 편집(CRISPR) 및 기타 첨단 생명공학 기술로 인해 생성되는 생물학적 데이터의 양과 복잡성이 증가하고 있다는 점입니다. 시퀀싱 비용이 지속적으로 감소함에 따라 더 많은 연구자와 기관이 대규모 데이터세트를 생성하고 있으며, 이를 분석 및 해석하기 위해서는 첨단 계산 툴이 필요하므로 계산생물학 솔루션에 대한 수요가 증가하고 있습니다. 또 다른 중요한 요인은 맞춤형 의료의 부상입니다. 맞춤형 의료는 유전정보를 분석하고 환자 개개인의 고유한 유전자 프로파일에 따라 치료를 조정하기 위해 계산모델에 크게 의존하고 있습니다. 이러한 정밀의료로의 전환은 신약개발, 진단, 치료계획에 있으며, 계산생물학에 새로운 기회를 창출하고 있습니다. 또한 생명과학 분야에서 인공지능(AI)과 머신러닝의 활용 확대는 계산생물학의 도입을 가속화하고 있습니다. 이러한 기술은 패턴 식별, 결과 예측, 연구 전략 최적화를 위한 강력한 툴을 제공하기 때문입니다. 계산생물학과 바이오인포매틱스, 생명공학 산업(특히 제약 및 생명공학 기업)과의 통합이 진행되고 있는 것도 주요 성장 요인으로 꼽힙니다. 기업은 계산 툴을 활용해 신약개발을 가속화하고 연구개발비용을 절감하기 위해 노력하고 있기 때문입니다. 또한 팬데믹과 같은 세계 보건 이슈로 인해 더 나은 질병 모델링의 필요성이 대두됨에 따라 연구자 및 의료계는 질병 발생 예측, 역학 동향 모델링, 새로운 치료법 개발을 가속화하기 위해 계산생물학에 대한 투자를 추진하고 있습니다. 마지막으로 정부 및 학술기관의 유전체 연구와 생명과학 혁신에 대한 자금 지원은 계산생물학 시장의 성장을 더욱 가속화하고 있습니다. 공공 부문과 민간 부문이 헬스케어, 농업, 환경 관리에 혁명을 일으킬 수 있는 잠재력을 인식하고 있기 때문입니다. 이러한 요인들이 결합되어 계산생물학이 현대 과학과 의학의 가장 시급한 문제를 해결하는 데 필수적인 툴이 되면서 그 급속한 확장이 강조되고 있습니다.

부문 :

서비스(계약 서비스, 사내 서비스), 애플리케이션(Drug Discovery·질환 모델링, 세포·생물 시뮬레이션, 임상시험, 전임상 약물 개발, 인체 시뮬레이션 소프트웨어), 최종 사용(상업, 학술, 산업)

조사 대상 기업의 예

  • Certara LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Therapeutics
  • Rosa & Co. LLC
  • Schrodinger LLC
  • Simulations Plus, Inc.
  • Strand Life Sciences Pvt., Ltd.

AI INTEGRATIONS

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM이나 산업별 SLM에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계의 기타 지역

제4장 경쟁

KSA

Global Computational Biology Market to Reach US$28.4 Billion by 2030

The global market for Computational Biology estimated at US$10.5 Billion in the year 2024, is expected to reach US$28.4 Billion by 2030, growing at a CAGR of 18.0% over the analysis period 2024-2030. Drug Discovery & Disease Modelling Application, one of the segments analyzed in the report, is expected to record a 18.0% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth in the Cellular & Biological Simulation Application segment is estimated at 16.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 17.1% CAGR

The Computational Biology market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.3 Billion by the year 2030 trailing a CAGR of 17.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.0% and 15.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.1% CAGR.

Global Computational Biology Market - Key Trends and Drivers Summarized

How Is Computational Biology Transforming Research and Innovation in Life Sciences?

Computational biology is revolutionizing the field of life sciences by applying mathematical models, algorithms, and data analysis techniques to biological data, helping researchers unlock complex biological processes that were previously inaccessible. This interdisciplinary field integrates biology, computer science, and mathematics to solve biological problems, ranging from understanding gene expression and protein interactions to simulating the behavior of entire biological systems. Computational biology plays a critical role in modern research, especially in genomics, proteomics, systems biology, and drug discovery. It allows scientists to analyze large datasets-such as the human genome or microbiome data-rapidly and with unprecedented accuracy, leading to breakthroughs in personalized medicine, disease modeling, and evolutionary biology. As biological data continues to grow exponentially, the importance of computational biology increases, providing researchers with the tools to extract meaningful insights, develop new therapies, and understand the underlying mechanisms of life at the molecular and systemic levels.

What Technological Advancements Are Driving Computational Biology?

The field of computational biology has seen significant advances, largely driven by technological innovations that have expanded its capacity to handle and interpret vast amounts of biological data. One of the most influential technologies is next-generation sequencing (NGS), which has drastically reduced the time and cost required to sequence DNA and RNA, generating massive datasets that computational biology tools can process to uncover genetic variations, mutations, and patterns. Coupled with advancements in high-performance computing (HPC), researchers can now analyze complex biological networks and large datasets in a fraction of the time previously required. Artificial intelligence (AI) and machine learning are also transforming computational biology, enabling predictive modeling, pattern recognition, and automated hypothesis generation in areas such as drug discovery and personalized medicine. AI algorithms can sift through massive biological datasets to predict drug-target interactions, patient responses to treatments, and even the emergence of disease outbreaks. Additionally, cloud computing has made computational biology more accessible by providing scalable resources for data storage and processing, fostering collaboration across global research teams. These advancements have greatly accelerated research, allowing for more sophisticated models of biological systems, faster drug discovery, and deeper insights into complex diseases.

How Is Computational Biology Applied Across Different Research Areas?

Computational biology is applied across numerous fields within the life sciences, playing a pivotal role in genomics, drug discovery, systems biology, and evolutionary biology. In genomics, computational tools are used to sequence and analyze entire genomes, providing insights into genetic disorders, evolution, and individual responses to drugs, which form the foundation of personalized medicine. By identifying genetic variants and predicting their impact on protein function, computational biology enables researchers to better understand the genetic basis of diseases like cancer, Alzheimer’s, and diabetes. In drug discovery, computational models simulate how drug candidates interact with biological targets, significantly reducing the time and cost required for laboratory testing. These models help predict the efficacy and safety of potential therapies before they enter clinical trials, streamlining the drug development pipeline. In systems biology, computational approaches are used to model entire biological systems-such as metabolic pathways or cellular processes-to understand how interactions between genes, proteins, and metabolites lead to complex behaviors in organisms. This holistic understanding is crucial for identifying potential therapeutic targets and for developing treatments for multifactorial diseases. Evolutionary biology also benefits from computational biology, where large-scale datasets allow researchers to trace the evolutionary history of species, understand the impact of natural selection on genomes, and predict how organisms might adapt to environmental changes. Across these diverse fields, computational biology enables scientists to make sense of biological complexity and translate data into actionable insights.

What Factors Are Driving the Growth of the Computational Biology Market?

The growth in the computational biology market is driven by several key factors, reflecting both technological advancements and evolving research needs. One of the primary drivers is the increasing volume and complexity of biological data being generated from next-generation sequencing (NGS), CRISPR gene editing, and other advanced biotechnologies. As the cost of sequencing continues to drop, more researchers and institutions are generating large datasets that require sophisticated computational tools to analyze and interpret, fueling the demand for computational biology solutions. Another important factor is the rise of personalized medicine, which relies heavily on computational models to analyze genetic information and tailor treatments to individual patients based on their unique genetic profiles. This shift towards precision medicine is creating new opportunities for computational biology in drug discovery, diagnostics, and treatment planning. Additionally, the growing use of artificial intelligence (AI) and machine learning in life sciences is accelerating the adoption of computational biology, as these technologies provide powerful tools for identifying patterns, predicting outcomes, and optimizing research strategies. The increasing integration of computational biology with bioinformatics and biotechnology industries, particularly in pharmaceutical and biotechnology companies, is also a major growth driver, as businesses seek to leverage computational tools to expedite drug discovery and reduce R&D costs. Furthermore, the need for better disease modeling, especially in light of global health challenges such as pandemics, is pushing researchers and healthcare institutions to invest in computational biology to predict disease outbreaks, model epidemiological trends, and develop new treatments more rapidly. Lastly, government and academic funding for genomics research and life sciences innovation is further propelling the growth of the computational biology market, as public and private sectors recognize its potential to revolutionize healthcare, agriculture, and environmental management. These factors collectively underscore the rapid expansion of computational biology, as it becomes an essential tool for solving some of the most pressing challenges in modern science and medicine.

SCOPE OF STUDY:

The report analyzes the Computational Biology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service (Contract Services, In-House Services); Application (Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development, Human Body Simulation Software); End-Use (Commercial, Academics, Industrial)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • Certara LP
  • Chemical Computing Group ULC
  • Compugen Ltd.
  • Dassault Systemes
  • Genedata AG
  • Insilico Biotechnology AG
  • Leadscope, Inc.
  • Nimbus Therapeutics
  • Rosa & Co. LLC
  • Schrodinger LLC
  • Simulations Plus, Inc.
  • Strand Life Sciences Pvt., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Global Economic Update
    • Computational Biology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Genomics and Bioinformatics Expand the Addressable Market for Computational Biology Solutions
    • Increasing Demand for Personalized Medicine Propels Growth of Computational Biology in Drug Discovery
    • Rising Use of AI and Machine Learning in Biological Data Analysis Strengthens the Business Case for Computational Biology
    • Growing Adoption of Computational Biology in Cancer Research Spurs Demand for Advanced Modeling Tools
    • Innovations in High-Throughput Sequencing Throw the Spotlight on Computational Biology for Data Processing
    • Surge in Synthetic Biology Research Accelerates Demand for Computational Biology in Genome Editing and Design
    • Increasing Focus on Systems Biology Drives Growth of Computational Tools for Complex Biological Network Modeling
    • Expansion of Biotechnology and Pharmaceutical R&D Generates Opportunities for Computational Biology in Drug Development
    • Growing Use of Computational Biology in Vaccine Development Strengthens Adoption in Immunology Research
    • Emerging Role of Computational Biology in Agriculture Expands Opportunities for Crop Improvement and Genetic Engineering
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Contract Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Contract Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for In-House Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for In-House Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Drug Discovery & Disease Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Drug Discovery & Disease Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Cellular & Biological Simulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Cellular & Biological Simulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Preclinical Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World 6-Year Perspective for Preclinical Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Human Body Simulation Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 14: World 6-Year Perspective for Human Body Simulation Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Commercial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 16: World 6-Year Perspective for Commercial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World 6-Year Perspective for Academics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 20: World 6-Year Perspective for Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 21: World Computational Biology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • JAPAN
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • CHINA
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • EUROPE
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Computational Biology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Computational Biology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
  • FRANCE
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • GERMANY
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • UNITED KINGDOM
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 82: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Rest of Europe 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 84: Rest of Europe Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Rest of Europe 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Computational Biology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 88: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Asia-Pacific 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 90: Asia-Pacific Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Asia-Pacific 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Service - Contract Services and In-House Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World 6-Year Perspective for Computational Biology by Service - Percentage Breakdown of Value Sales for Contract Services and In-House Services for the Years 2025 & 2030
    • TABLE 94: Rest of World Recent Past, Current & Future Analysis for Computational Biology by Application - Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of World 6-Year Perspective for Computational Biology by Application - Percentage Breakdown of Value Sales for Drug Discovery & Disease Modelling, Cellular & Biological Simulation, Clinical Trials, Preclinical Drug Development and Human Body Simulation Software for the Years 2025 & 2030
    • TABLE 96: Rest of World Recent Past, Current & Future Analysis for Computational Biology by End-Use - Commercial, Academics and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of World 6-Year Perspective for Computational Biology by End-Use - Percentage Breakdown of Value Sales for Commercial, Academics and Industrial for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제